Strategy and tactics of patients’ treatment with complicated forms of atopic dermatitis

Matushevskaya E.V.; Svirshchevskaya E.V.

doi:https://doi.org/10.17116/klinderma20212004115

Close metadata

Recommended articles:

Infectious factors in atopic dermatitis, pharmaceutical possibilities (systematic literature review). Russian Journal of Clinical Dermatology and Venereology. 2025;(1):7-15

Epidemiology of M. genitalium infection. What is known?. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):143-152

Search of diagnostic and prognostic biomarkers of immunoinflammatory dermatoses by means of flow cytometry. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):170-177

Nucleotide sequence variants in IL4 and TNFA genes in patients with dermatoses and xerosis. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):178-184

Efficacy of combined therapy of prurigo adultorum with application of temgicoluril anxiolytic. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):210-216

The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104

Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59

Neoadjuvant drug therapy and oncological outcomes in patients with stage I–II breast cancer. P.A. Herzen Journal of Oncology. 2025;(1):5-12

A modern perspective on the pathogenesis of proliferative diabetic retinopathy. Russian Annals of Ophthalmology. 2025;(1):92-98

Characteristics, treatment features and in-hospital mortality of patients with myocardial infarction over 75 years old in Russia according to the REGION-IM registry. Russian Cardiology Bulletin. 2025;(1):22-38

Abstract:

Atopic dermatitis (AD) is a chronic, recurrent skin disease caused by disruption of the skin barrier, IgE-mediated hypersensitivity to environmental factors, and immune imbalance. The issues of the etiology and pathogenesis of AD where the leading and predisposing role are played by the features of the skin barrier are considered. These processes lead to a change in the skin microbiome and the triggering of the cytokine and chemokine reactions of innate immunity with the involvement of the immune system cells. It was shown that the microbial flora of the skin in a significant part of patients with allergic dermatoses causes complications during disease. The data of foreign and Russian studies on the pathogenesis and treatment of AD are presented. The main directions in the treatment of AD are highlighted based on international and Russian clinical guidelines. The place of topical combined drugs in the treatment of complicated forms of AD and dermatoses of combined etiology was determined. The advantages of micronized drugs have been substantiated: high therapeutic efficacy and low risk of the undesirable phenomena formation. The efficacy and safety of the topical preparation betamethasone (micronized) + gentamicin + clotrimazole cream has been shown in the wide practice of a dermatovenerologist. Based on data from foreign and Russian studies it has been shown that the use of the combined drug betamethasone (micronized) + gentamicin + clotrimazole in the treatment of complicated forms of AD is effective and safe and meets the requirements of modern principles and standards of treatment.

Keywords:

atopic dermatitis

pathogenesis

therapy

topical corticosteroids

combination therapy

betamethasone + gentamicin + clotrimazole cream

Authors:

Matushevskaya E.V.

Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies FMBA

ORCID: 0000-0003-4583-0617

Svirshchevskaya E.V.

Shemyakin-Ovchinnikov Institute of bioorganic chemistry RAS

Received:

20.05.2021

Accepted:

11.06.2021

Close metadata

References:

Kubanova AA, Kubanov AA, Melekhina LE, Bogdanova EV. Analysis of the incidence of diseases of the skin and subcutaneous tissue in the Russian Federation for the period 2003—2016. Bulletin of Dermatology and Venereology. 2017;6:22-33. (In Russ.). https://doi.org/10.25208/0042-4609-2017-93-6-22-33
Kubanov AA, Bogdanova EV. Organization and results of medical care in the field of dermatovenerology in the Russian Federation. Results of 2018. Bulletin of Dermatology and Venereology. 2019;95(4):8-23. (In Russ.). https://doi.org/10.25208/0042-4609-2019-95-4-8-23
Weidinger S, Willis-Owen SA, Kamatani Y, Baurecht H, Morar N, Liang L, Edser P, Street T, Rodriguez E, O’Regan GM, Beattie P, Fölster-Holst R, Franke A, Novak N, Fahy CM, Winge MC, Kabesch M, Illig T, Heath S, Söderhäll C, Melén E, Pershagen G, Kere J, Bradley M, Lieden A, Nordenskjold M, Harper JI, McLean WH, Brown SJ, Cookson WO, Lathrop GM, Irvine AD, Moffatt MF. A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet. 2013;22(23):4841-4856. https://doi.org/10.1093/hmg/ddt317
Shen C, Liu L, Jiang Z, Zheng X, Meng L, Yin X, Gao J, Sheng Y, Gao J, Li Y, Zhou F, Xiao F, Sun L, Cui Y, Yang S, Zuo X, Zhang X. Four genetic variants interact to confer susceptibility to atopic dermatitis in Chinese Han population. Mol Genet Genomics. 2015;290(4):1493-1498. https://doi.org/10.1007/s00438-015-1014-x
Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Sakashita M, Yamada T, Fujieda S, Tanaka S, Doi S, Miyatake A, Enomoto T, Nishiyama C, Nakano N, Maeda K, Okumura K, Ogawa H, Ikeda S, Noguchi E, Sakamoto T, Hizawa N, Ebe K, Saeki H, Sasaki T, Ebihara T, Amagai M, Takeuchi S, Furue M, Nakamura Y, Tamari M. Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population. Nat Genet. 2012;44(11):1222-1226. https://doi.org/10.1038/ng.2438
Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-1072. https://doi.org/10.1111/j.1600-0625.2008.00786.x
Gutowska-Owsiak D, de La Serna JB, Fritzsche M, Naeem A, Podobas EI, Leeming M, Colin-York H, O’Shaughnessy R, Eggeling C, Ogg GS. Orchestrated control of filaggrin-actin scaffolds underpins cornification. Cell Death Dis. 2018;9(4):412. https://doi.org/10.1038/s41419-018-0407-2
Svirshchevskaya EV, Matushevskaya EV The role of lipids in the barrier properties of the skin. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2019;18(3):360-365. (In Russ.). https://doi.org/10.17116/klinderma201918031360
Ng YT, Chew FT. A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia. World Allergy Organ J. 2020;13(11): 100477. https://doi.org/10.1016/j.waojou.2020.100477
Roduit C, Frei R, Depner M, Karvonen AM, Renz H, Braun-Fahrländer C, Schmausser-Hechfellner E, Pekkanen J, Riedler J, Dalphin JC, von Mutius E, Lauener RP; the PASTURE study group, Hyvärinen A, Kirjavainen P, Remes S, Roponen M, Dalphin ML, Kaulek V, Ege M, Genuneit J, Illi S, Kabesch M, Schaub B, Pfefferle PI, Doekes G. Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood. JAMA Pediatr. 2017;171(7):655-662. https://doi.org/10.1001/jamapediatrics.2017.0556
Suárez-Fariñas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132(2):361-370. https://doi.org/10.1016/j.jaci.2013.04.046
Roguedas-Contios AM, Misery L. What is intrinsic atopic dermatitis? Clin Rev Allergy Immunol. 2011;41(3):233-236. https://doi.org/10.1007/s12016-011-8276-9
Martel BC, Litman T, Hald A, Norsgaard H, Lovato P, Dyring-Andersen B, Skov L, Thestrup-Pedersen K, Skov S, Skak K, Poulsen LK. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Exp Dermatol. 2016;25(6):453-459. https://doi.org/10.1111/exd.12967
Kabashima-Kubo R, Nakamura M, Sakabe J, Sugita K, Hino R, Mori T, Kobayashi M, Bito T, Kabashima K, Ogasawara K, Nomura Y, Nomura T, Akiyama M, Shimizu H, Tokura Y. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. J Dermatol Sci. 2012;67(1):37-43. https://doi.org/10.1016/j.jdermsci.2012.04.004
Ahlström MG, Thyssen JP, Wennervaldt M, Menné T, Johansen JD. Nickel allergy and allergic contact dermatitis: A clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis. 2019;81(4):227-241. https://doi.org/10.1111/cod.13327
Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP. Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):70-78. https://doi.org/10.1016/j.jaad.2017.02.001
Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI; ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009; 124(6):1251-8.e23. https://doi.org/10.1016/j.jaci.2009.10.009
Luss LA. Psychosomatic disorders in patients with atopic dermatitis. Doktor.Ru. Ser.: Allergology. Dermatology. 2010;2(53):55-58.
Nomura T, Honda T, Kabashima K. Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers. Int Immunol. 2018;30(9):419-428. https://doi.org/10.1093/intimm/dxy015
Young VB. The role of the microbiome in human health and disease: an introduction for clinicians. BMJ. 2017;356:j831. https://doi.org/10.1136/bmj.j831
Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, Skoog T, Jules-Clement G, Feld M, Barrientos-Somarribas M, Sinkko H, van den Bogaard EH, Zeeuwen PLJM, Rikken G, Schalkwijk J, Niehues H, Däubener W, Eller SK, Alexander H, Pennino D, Suomela S, Tessas I, Lybeck E, Baran AM, Darban H, Gangwar RS, Gerstel U, Jahn K, Karisola P, Yan L, Hansmann B, Katayama S, Meller S, Bylesjö M, Hupé P, Levi-Schaffer F, Greco D, Ranki A, Schröder JM, Barker J, Kere J, Tsoka S, Lauerma A, Soumelis V, Nestle FO, Homey B, Andersson B, Alenius H. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019; 10(1):4703. https://doi.org/10.1038/s41467-019-12253-y
Nowicka D, Nawrot U. Contribution of Malassezia spp. to the development of atopic dermatitis. Mycoses. 2019;62(7):588-596. https://doi.org/10.1111/myc.12913
Brodská P, Panzner P, Pizinger K, Schmid-Grendelmeier P. IgE-mediated sensitization to malassezia in atopic dermatitis: more common in male patients and in head and neck type. Dermatitis. 2014;25(3):120-126. https://doi.org/10.1097/DER.0000000000000040
Sonesson A, Bartosik J, Christiansen J, et al. Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity. Acta Derm Venereol 2013;93:340-345.
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. https://doi.org/10.1111/jdv.14891
Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132. https://doi.org/10.1016/j.jaad.2014.03.023
Khismatulina IM, Lisovskaya SA, Faizullina EV, Gusarova ES, Valieva RI. Study of the fungicidal activity of topical combined glucocorticosteroid drugs used in the treatment of chronic recurrent infected dermatoses. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2020;19(6):853-857. (In Russ.). https://doi.org/10.17116/klinderma202019061863
Ustinov MV, Ustinova EV, Chaplygin AV, Kotrekhova LP, Tsurupa EN, Chaplygin NV. Rational local therapy of acquired dyshidrotic palmar-plantar dermatoses. Effective pharmacotherapy. 2021;17(1):8-12. (In Russ.).
Khaldin AA, Zhukova OV. An open randomized comparative study to study the efficacy and safety of multicomponent drugs for external use of domestic and foreign production in the complex therapy of eczema. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2019;18(3):1-11. (In Russ.). https://doi.org/10.17116/klinderma201918031327
Matushevskaya EV, Svirshchevskaya EV. Micronization technologies for drugs: new possibilities of topical glucocorticosteroids in dermatology. Russian Journal of Clinical Dermatology and Venereology = Klinichaskaya dermatologiya i venerologiya. 2017;1:44-49. (In Russ.). https://doi.org/10.17116/klinderma201716143-48